Safety, efficacy, and performance of new discrimination algorithms to reduce inappropriate and unnecessary shocks: The PainFree SST clinical study design

Europace

Volumn 13, Issue 10, 2011, Pages 1484-1493

  Auricchio, Angelo ^a   Meijer, Albert ^b   Kurita, Takashi ^c   Schloss, Edward ^d   Brinkman, Karin ^e   Claessens Van Ooijen, Marieke ^f   Sterns, Laurence ^g  

^a DIVISION OF CARDIOLOGY   (Switzerland)

^b CATHARINA HOSPITAL   (Netherlands)

^c KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d CHRIST HOSPITAL   (United States)

^e MEDTRONIC INC   (United States)

^f MEDTRONIC BAKKEN RESEARCH CENTER   (Netherlands)

^g ROYAL JUBILEE HOSPITAL   (Canada)

Author keywords

Cardiac resynchronization therapy; Implantable cardioverter defibrillator; Inappropriate shock; Shock reduction

Indexed keywords

ALGORITHM; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVERSION; CLINICAL TRIAL (TOPIC); DEFIBRILLATION; DEFIBRILLATOR; DEVICE; ELECTRIC SHOCK; FOLLOW UP; HEALTH CARE UTILIZATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTATION; INAPPROPRIATE SHOCK; MAJOR CLINICAL STUDY; MEDICAL TECHNOLOGY; MONITOR; MULTICENTER STUDY (TOPIC); PAIN; PATIENT SAFETY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ALGORITHMS; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT SAFETY; HUMANS; INTERNATIONAL COOPERATION; PROSPECTIVE STUDIES; RESEARCH DESIGN; SENSITIVITY AND SPECIFICITY; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 80053413667     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur133     Document Type: Article

References (43)

1. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37. (Pubitemid 40110811)
2. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341:1882-90.
3. Greenberg H, Case RB, Moss AJ, Brown MW, Carroll ER, Andrews ML. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II). J Am Coll Cardiol 2004;43:1459-65. (Pubitemid 38496355)
4. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83. (Pubitemid 34984635)
5. Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 2010;346:877-83.
6. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004;350:2151-8. (Pubitemid 38637995)
7. Wilkoff BL, Hess M, Young J, Abraham WT. Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients. J Cardiovasc Electrophysiol 2004;15:1002-9. (Pubitemid 39281528)
8. Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P et al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 2008;51:1357-65. (Pubitemid 351443082)
9. Wilkoff BL, Ousdigian KT, Sterns LD, Wang ZJ, Wilson RD, Morgan JM. A comparison of empiric to physician-tailored programming of implantable cardioverterdefibrillators: results from the prospective randomized multicenter EMPIRIC trial. J Am Coll Cardiol 2006;48:330-9.
10. Passman R, Subacius H, Ruo B, Schaechter A, Howard A, Sears SF et al. Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study. Arch Intern Med 2007; 167:2226-32. (Pubitemid 350106743)
11. Sears SF, Todaro JF, Urizar G, Lewis TS, Sirois B, Wallace R et al. Assessing the psychosocial impact of the ICD: a national survey of implantable cardioverter defibrillator health care providers. Pacing Clin Electrophysiol 2000;23:939-45. (Pubitemid 30413599)
12. Freedenberg V, Thomas SA, Friedmann E. Anxiety and depression in implanted cardioverter-defibrillator recipients and heart failure: a review. Heart Fail Clin 2011;7:59-68.
13. Mishkin JD, Saxonhouse SJ, Woo GW, Burkart TA, Miles WM, Conti JB et al. Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock. J Am Coll Cardiol 2009;54:1993-2000.
14. Tung R, Zimetbaum P, Josephson ME. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol 2008;52:1111-21.
15. Dougherty CM. Psychological reactions and family adjustment in shock versus no shock groups after implantation of internal cardioverter defibrillator. Heart Lung 1995;24:281-91.
16. Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. JAMA 2006;295:165-71. (Pubitemid 43076435)
17. Stevenson WG, Wilber DJ, Natale A, Jackman WM, Marchlinski FE, Talbert T et al. Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial. Circulation 2008;118: 2773-82.
18. Gillberg J. Detection of cardiac tachyarrhythmias in implantable devices. J Electrocardiol 2007;40(Suppl. 6):S123-8. (Pubitemid 350052085)
19. Compton SJ. Clinical performance of the wavelet TM automatic electrogram template collection algorithm. J Am Coll Cardiol 2003;41:116A.
20. Klein GJ, Gillberg JM, Tang A, Inbar S, Sharma A, Unterberg-Buchwald C et al. Improving SVT discrimination in single-chamber ICDs: a new electrogram morphology-based algorithm. J Cardiovasc Electrophysiol 2006;17:1310-9. (Pubitemid 44808550)
21. Wilkoff BL, Kuhlkamp V, Volosin K, Ellenbogen K, Waldecker B, Kacet S et al. Critical analysis of dual-chamber implantable cardioverter-defibrillator arrhythmia detection : results and technical considerations. Circulation 2001;103:381-6. (Pubitemid 32105977)
22. Swerdlow CD, Gunderson BD, Ousdigian KT, Abeyratne A, Stadler RW, Gillberg JM et al. Downloadable algorithm to reduce inappropriate shocks caused by fractures of implantable cardioverter-defibrillator leads. Circulation 2008;118:2122-9.
23. Swerdlow CD, Gunderson BD, Ousdigian KT, Abeyratne A, Sachanandani H, Ellenbogen KA. Downloadable software algorithm reduces inappropriate shocks caused by implantable cardioverter-defibrillator lead fractures: a prospective study. Circulation 2010;122:1449-55.
24. Kallinen LM, Hauser RG, Tang C, Melby DP, Almquist AK, Katsiyiannis WT et al. Lead integrity alert algorithm decreases inappropriate shocks in patients who have Sprint Fidelis pace-sense conductor fractures. Heart Rhythm 2010;7: 1048-55.
25. EuroQol. EuroQol-a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990;16:199-208.
26. Kuhl EA, Dixit NK, Walker RL, Conti JB, Sears SF. Measurement of patient fears about implantable cardioverter defibrillator shock: an initial evaluation of the Florida Shock Anxiety Scale. Pacing Clin Electrophysiol 2006;29:614-8. (Pubitemid 43886613)
27. Volosin KJ, Exner DV, Wathen MS, Sherfesee L, Scinicariello AP, Gillberg JM. Combining shock reduction strategies to enhance ICD therapy: a role for computer modeling. J Cardiovasc Electrophysiol 2010;22:208-9.
28. Sweeney MO, Wathen MS, Volosin K, Abdalla I, DeGroot PJ, Otterness MF et al. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial. Circulation 2005;111:2898-905. (Pubitemid 40814182)
29. Thomas SA, Friedmann E, Gottlieb SS, Liu F, Morton PG, Chapa DW et al. Changes in psychosocial distress in outpatients with heart failure with implantable cardioverter defibrillators. Heart Lung 2009;38:109-20.
30. Cevik C, Perez-Verdia A, Nugent K. Implantable cardioverter defibrillators and their role in heart failure progression. Europace 2009;11:710-5.
31. Germano JJ, Reynolds M, Essebag V, Josephson ME. Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic?. Am J Cardiol 2006;97:1255-61.
32. Friedman PA, McClelland RL, Bamlet WR, Acosta H, Kessler D, Munger TM et al. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study. Circulation 2006;113:2871-9. (Pubitemid 44297227)
33. Dorian P, Philippon F, Thibault B, Kimber S, Sterns L, Greene M et al. Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverterdefibrillator. Heart Rhythm 2004;1:540-7. (Pubitemid 39462711)
34. Deisenhofer I, Kolb C, Ndrepepa G, Schreieck J, Karch M, Schmieder S et al. Do current dual chamber cardioverter defibrillators have advantages over conventional single chamber cardioverter defibrillators in reducing inappropriate therapies? A randomized, prospective study. J Cardiovasc Electrophysiol 2001;12:134-42. (Pubitemid 32171500)
35. Toquero J, Alzueta J, Mont L, Lozano IF, Barrera A, Berruezo A et al. Morphology discrimination criterion wavelet improves rhythm discrimination in singlechamber implantable cardioverter-defibrillators: Spanish Register of morphology discrimination criterion wavelet (REMEDIO). Europace 2009;11:727-33.
36. Kallinen LM, Hauser RG, Lee KW, Almquist AK, Katsiyiannis WT, Tang CY et al. Failure of impedance monitoring to prevent adverse clinical events caused by fracture of a recalled high-voltage implantable cardioverter-defibrillator lead. Heart Rhythm 2008;5:775-9.
37. Swerdlow CD, Friedman PA. Advanced ICD troubleshooting: part II. Pacing Clin Electrophysiol 2006;29:70-96.
38. Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW et al. Strategic programming of detection and therapy parameters in implantable cardioverterdefibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol 2008;52:541-50.
39. Hugl B, Israel CW, Unterberg C, Lawo T, Geller JC, Kennis IM et al. Incremental programming of atrial anti-tachycardia pacing therapies in bradycardia-indicated patients: effects on therapy efficacy and atrial tachyarrhythmia burden. Europace 2003;5:403-9. (Pubitemid 37336970)
40. Boriani G, Biffi M, Martignani C, Valzania C, Diemberger I, Bertini M et al. Is cardiac resynchronization therapy cost-effective?. Europace 2009;11(Suppl. 5): v93-7.
41. Sweeney MO, Ellenbogen KA, Tang ASL, Whellan D, Mortensen PT, Sherfesee L et al. Differences in Effects of Electrical Therapy Type on Health Care Utilization in the MVP ICD Trial. In HRS Conference. Denver, USA; 2010.
42. Keren A, Sears SF, Nery P, Shaw J, Green MS, Lemery R et al. Psychological adjustment in ICD patients living with advisory fidelis leads. J Cardiovasc Electrophysiol 2010;22:57-63.
43. Bostwick JM, Sola CL. An updated review of implantable cardioverter/defibrillators, induced anxiety, and quality of life. Heart Fail Clin 2011;7:101-8.